CIRCULAR GENOMICS
Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostic and therapeutic assays to facilitate the treatment of psychiatric and neurological diseases. The company was founded in 2021 and is headquartered in Albuquerque, New Mexico.
CIRCULAR GENOMICS
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2021-01-01
Address:
Albuquerque, New Mexico, United States
Country:
United States
Website Url:
http://www.circulargenomics.com
Total Employee:
1+
Status:
Active
Total Funding:
4.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Google GStatic Google Static Content Google Cloud
Current Advisors List
Current Employees Featured
Founder
Investors List
Mountain Group Capital
Mountain Group Capital investment in Seed Round - Circular Genomics
Cottonwood Technology Fund
Cottonwood Technology Fund investment in Seed Round - Circular Genomics
Tramway Venture Partners
Tramway Venture Partners investment in Seed Round - Circular Genomics
Official Site Inspections
http://www.circulargenomics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Circular Genomics"
Circular Genomics | Precision Psychiatry
Circular Genomics is a pioneering precision psychiatric and neurologic medicine biotechnology company, using advanced technology and proprietary data to uncover insights for …See details»
Circular Genomics - Crunchbase Company Profile & Funding
Circular Genomics may be growing as it successfully closed a funding round in 2023, securing $1.5 million. This influx of capital suggests investor confidence and the potential for the …See details»
Circular Genomics - LinkedIn
Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions ...See details»
Circular Genomics Company Profile | Management and Employees …
Www.circulargenomics.com . Circular Genomics Profile and History. Circular Genomics is a pioneer in precision medicine, leveraging circular RNA biomarkers and bioinformatics to …See details»
Paul Sargeant - Circular Genomics
Paul Sargeant is the President and Chief Executive Officer of Circular Genomics. He has a 25-year global career, having worked in US, Europe, and Asia with Fortune 100 and venture-backed start-ups at the intersection between science …See details»
Circular Genomics Raises $8.3 Million for Debut of Circular RNA …
Jan 24, 2024 /PRNewswire/ -- Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today announced the closing...See details»
Circular Genomics - PitchBook
Circular Genomics General Information Description. Developer of RNA-based diagnostic assay designed for the treatment of depressive disorders. The company's circular RNA diagnostics …See details»
Circular Genomics - Company Profile - Tracxn
Oct 11, 2024 Circular Genomics ranks 586th among 2404 active competitors. 865 of its competitors are funded while 547 have exited. Overall, Circular Genomics and its competitors …See details»
Circular Genomics Raises $8.3 Million for Debut of Circular RNA …
Jan 24, 2024 Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today announced the closing of an $8.3 Million Series A …See details»
Local Startup Circular Genomics Closes $8.3M Investment Round
Jan 26, 2024 Circular Genomics, a local startup commercializing technology developed at the University of New Mexico, has closed on an $8.3 million Series A investment round led by …See details»
Circular Genomics Raises $8.3 Million for Debut of Circular RNA …
Jan 24, 2024 Albuquerque, New Mexico, January 24, 2024 - Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today …See details»
Local Bioscience Startup Circular Genomics Raises $1.5M
Mar 28, 2023 Circular Genomics has recently raised $1.5 million to further expand its research and development operations and grow the company’s team. This is part of a $3.2 million …See details»
Local Startup Circular Genomics Closes $4.5M Series Seed …
Jan 8, 2022 Local startup Circular Genomics recently closed on a $4.5M series seed investment round for their innovative research on circular RNA to target effective treatment options for …See details»
Circular Genomics - TechCrunch
Aug 23, 2023 Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.See details»
Circular Genomics Strengthens Leadership Team with Key …
Feb 26, 2024 New appointments hired in preparation for the launch of the world's first circular RNA-based clinical prediction test for antidepressant therapies.Albuquerque, N.M., Feb. 26, …See details»
Circular Genomics Announces Two Significant Steps Forward
Jul 11, 2023 Contact Data Jamie Dickerman Circular Genomics 505-720-2195 [email protected]See details»
Circular Genomics Closes $4.5M Series Seed Investment
Alex Hafez – [email protected]; +1 505 677-0512 Dave Blivin – [email protected]; +1 505 412-8537 Waneta Tuttle – [email protected]; +1 505 710-1463 . Recent …See details»
Circular Genomics | Circular RNA
Circular RNAs have been shown to be important for brain development, maturation, function, and aging and have been linked to many psychiatric and neurological disorders, including major …See details»
Circular Genomics | Precision Psychiatry
Apr 26, 2023 Circular Genomics is advancing precision medicine through our novel circular RNA approach for the accurate diagnosis and treatment of psychiatric and neurological disorders.See details»